Investment & Market Intelligence

The Investor

The Signal

DeepSeek raised API prices as it reopened a $74B round at 165x revenue.

Meta, meanwhile, priced Muse Code's contributor tier at a tenth of Claude to absorb its own compute spend. Neither firm needs tokens to be profitable, which is the awkward part if the pricing model you are underwriting this quarter assumes rational token economics. Canva already guided growth to 20% after cost-to-serve broke its freemium math, and Canva had no strategic reason to subsidize anything.

In Play

  1. Token Prices Set by Companies That Don't Need the Margin

    DeepSeek announced a significant API price increase without explanation, per The Information, while reopening a 50B yuan round at a 500B yuan ($74B) valuation on roughly $400-500M of annualized revenue. In the same window Meta shipped Muse Code with a contributor tier it claims is more than 10x cheaper than Claude and Codex. The inference floor underwriting your app-layer margin models is now set by one capacity-constrained lab and one advertising business absorbing its own compute.

    Ask Clarity
    Try
  2. Inference Landed in Cost of Goods Sold at the Application Layer

    Canva pre-warned investors that annual revenue growth will slow to 20% and paused an AI rollout it expected to drive paid subscriptions, per The Information: demand exceeded plan and cost too much to serve. Its COO said serving free users was once 'very low' cost and that 'the unit economics changed.' For your PLG and freemium marks, the binding constraint moved from adoption to cost-to-serve — a different valuation regime than the one those marks were set in.

    Ask Clarity
    Try
  3. Visa Removed the Last Independent Behavioral-Biometrics Asset

    Visa agreed to buy BioCatch for $2.4B, 2.4x the $1B it paid for Featurespace, per TLDR Fintech, taking roughly $3.4B of owned fraud technology inside one network. Mastercard is answering with partnerships — Fiserv for enterprise merchant value-added services, Borderless.xyz for crypto credentials — and owns no comparable behavioral data asset. Your identity and fraud comp set re-rated on scarcity Visa manufactured, which is event-driven rather than structural.

    Ask Clarity
    Try
  4. Alphabet's AI Bench Loosened and Its AI Unit Went Cash-Flow Negative

    Demis Hassabis moved to Alphabet chief scientist and DeepMind chairman. Jeff Dean left after 27 years alongside Sanjay Ghemawat, Oriol Vinyals and Quoc Le to found Discovery Loop, backed by Radical Ventures and Khosla Ventures at undisclosed terms. MIT Technology Review reports Google's AI unit turned cash-flow negative. Alphabet fell 4% on the reorg, which prices leadership as a people risk rather than a capex line.

    Ask Clarity
    Try
  5. Private AI Obligations Sit Outside the Reported Balance Sheet

    OpenAI reportedly carried no debt and under $750M of lease obligations as of March 31, 2026, against roughly $665B of purchase commitments for chips, power and capacity across Microsoft, Oracle, Amazon and Stargate, per The Information's review of company financial statements. It reportedly spent $46M on buildings and equipment in Q1 2026, less than Salesforce. The figures are unaudited, and marking late-stage AI secondaries off a reported capital structure underwrites an unlevered company that does not exist.

    Ask Clarity
    Try

Deep Dives

Two Companies Now Set the Token Price, and Neither Needs It to Be Profitable

Every AI application mark in the book was underwritten on an input price that turns out to be a strategic choice made by parties earning their return somewhere else.

Opposite mechanics, identical consequence

Meta's motive is compute absorption: Muse Code reportedly earns revenue from AI while the company spends heavily on data centers, so the contributor tier isn't priced against a gross margin at all, and Alexandr Wang naming Claude and Codex as the targets tells you the profit motive sits in a different P&L. DeepSeek runs it backwards, or rather runs the more interesting version backwards: demand for V4-Flash overwhelming finite capacity, at a firm whose founder told investors profit was not the priority. One discounts because tokens are a byproduct, the other raises because tokens are rationed. Neither is a cost curve, and that is the whole finding.

The buyer side already behaves this way

Microsoft now gives each internal department a limited pool of AI tokens to cap GitHub Copilot inference cost. Amazon, Google and Microsoft are committing roughly $600B of capex, and AWS says publicly it won't have enough capacity to meet demand through 2027. The largest AI spender on earth put a budget ceiling on its own flagship AI product in the quarter it bought more capacity than anyone. Infrastructure scarcity is contracted and underwritable; application-layer consumption has entered budget-committee discipline.

The application layer has said it out loud twice. Canva's COO: serving free users used to be "very low" cost, and with AI "those costs became much higher. The unit economics changed." Figma's CFO, on products still in beta: "we bear the cost of inference without offsetting consumption revenue". Figma reported a $370M quarter, guided growth down from 48% to 36%, and fell roughly 15% in a session. An unpriced beta feature is an open-ended liability with no end date.


What it costs when nobody meters the loop

a16z's Yoko Li ran Anthropic's own widely-copied loop example against a page whose achievable Lighthouse score she capped near 89. The first $1.40 moved the score from 26 to 89. The remaining $2.84, 67% of the $4.24 bill, bought exactly zero points, with per-turn cost rising as the transcript grew. A Haiku evaluator quietly billed $0.67 of its own, and when Claude correctly declared the goal impossible around try five, that evaluator bounced the verdict back 14 times. Nobody saw any of it until the trace was read afterward. The returns curve underneath is logarithmic: one web-agent benchmark went from 38.8% to 43.2% success between one sample and ten, then bought 0.2 additional points for double the tokens at twenty. n=1, benchmarks unnamed, directional rather than audit-grade.

Where the sources diverge

One reading treats funded pain as a sourcing lane: distillation, routers, semantic caching, cost observability. Possibly right. But both companies with the most acute pain chose to build in-house, and Canva's proprietary model wasn't ready in time, which is precisely what forced the rollout pause and the guidance cut. Either the vendors get bought into that gap, or the incumbents ship their own models a quarter late and eat the guidance. The second, held loosely: model timelines now sit on the critical path to revenue guidance, and hours spent making inference cheap are hours not spent shipping the feature meant to pay for it. Treat the vendor claim that in-house models are cheaper and faster than frontier alternatives as unaudited.

An input price set by a company that does not need margin on it is not a cost curve; it is a policy, and policies revert on someone else's schedule.

What to do

  1. Commission a +30% inference-cost stress test across every AI application holding this month, flagging any company whose gross margin breaks below 55% or whose runway breaches inside 12 months.

  2. Re-underwrite PLG and freemium marks on gross profit rather than ARR multiples before Q4 marks close, requiring cost per free monthly active user, cost per AI action, and margin at 3x adoption.

  3. Add two gates to every new AI application term sheet this quarter: a dated metering commitment for unpriced beta features, and a demonstrated 30-day path to a second inference provider or open weights.

Visa Manufactured Scarcity in Behavioral Biometrics

Mastercard's answer to $3.4B of owned fraud technology is a partnership roster, which tells you where the next check comes from and how long this comp survives.

The buyer is the less interesting half of this

Visa has now committed roughly $3.4B to owning fraud intellectual property outright (one billion for Featurespace, two point four billion for BioCatch), and is selling the result as a value-added services revenue line rather than carrying it as overhead, which is a decision about where the margin gets recognized at least as much as a decision about fraud. The stated rationale is defense against AI-enabled account takeover and scams, anchored to a 2025 identity-fraud loss pool of $38B. That loss-pool figure comes from Plaid/Javelin sponsored research: directionally credible, commercially framed, and worth triangulating against your own customer calls before it lands in an IC memo.

Mastercard is the party that changes the pipeline. It is answering capital-light — Fiserv for enterprise merchant value-added services, Borderless.xyz for crypto credentials on stablecoin rails — and owns no comparable behavioral or device telemetry asset, which is the part worth sitting with, because assembled partner stacks are replicable and proprietary device and behavioral data is not. Note also what three point four billion dollars of Visa capital is no longer available for. The strategic-buyer pool for identity, device intelligence, scam detection and first-party fraud just became more motivated and less price-sensitive. That motivation is now public.


The window has a shape and a clock

PlayerMoveCapital committedExposed gap
VisaBioCatch after Featurespace~$3.4BNetwork-neutrality doubts among non-Visa BioCatch clients
MastercardFiserv partnership; Borderless.xyz crypto credential~$0 disclosedNo owned fraud technology — structurally short
FiservGlobal partnership tied to one networkNot disclosedLoses rail-agnostic merchants

Two consequences follow. BioCatch's non-Visa and multi-network issuer accounts become churn candidates from announcement through integration, because switching costs in fraud tooling are high in steady state and temporarily depressed during ownership transitions, which opens a displacement window of roughly six to twelve months and does not reopen afterward. The second consequence matters more for pricing new diligence: the premium is event-driven, not structural. It exists because Visa cornered the supply of scaled behavioral-biometrics assets. It compresses the day Mastercard, Amex or a large processor closes its own.

What not to model

The temptation is to carry the $2.4B print forward as a category multiple into 2028 exit assumptions, which is precisely the error this comp invites. A scarcity-driven acquisition price tells you what the last available asset fetched when one motivated buyer had no substitute. It says nothing about the clearing price once a second scaled asset exists, or once a network decides building is cheaper than buying. Underwrite the next fraud or identity entry on durability of proprietary telemetry breadth and on regulated-buyer switching costs, and treat the strategic bid as upside rather than base case.

The counter-read deserves airtime, and it may well be the right one: network-neutrality concerns could prove weaker than the integration thesis assumes, because issuers rarely rip out working fraud infrastructure over ownership optics alone, and Visa will price aggressively to keep them. If that holds, the displacement window is narrower than six months and the churn opportunity is mostly rhetorical.

A comp created by one buyer removing the last substitute is a scarcity print, not a market price — and it expires the moment a second buyer solves the same problem.

What to do

  1. Re-mark internal fraud, identity and behavioral-biometrics comp tables against the disclosed $2.4B purchase price within two weeks, labelling the premium event-driven rather than structural.

  2. Commission diligence this quarter on the owned risk-technology gaps at Mastercard, Amex and the large processors, mapping which independent assets sit in the acquisition path and at what scale threshold.

  3. Brief fraud and identity portfolio boards this quarter to run named-account displacement against multi-network issuer accounts while integration depresses switching costs.

Alphabet's AI Unit Went Cash-Flow Negative and Four Principals Walked

The reorg is a cost program with a press release attached; the recruitable bench it loosens and the price incumbents will pay for talent density are the parts that price.

The number that reframes the org chart

MIT Technology Review carried the detail the tape mostly declined to price: Google's AI unit went cash-flow negative, alongside a delayed flagship model, documented talent-war losses and reported morale problems. Set that against Hassabis becoming Alphabet chief scientist and DeepMind chairman while Koray Kavukcuoglu takes the operating seat reporting to Pichai, and the announcement reads less like a research pivot than a cost program wearing a research pivot's clothes. The working industry assumption has been that hyperscaler capex is effectively unlimited. There is now a counter-example, printed in a cash flow statement, at the most profitable AI incumbent in the world.

How much actually changed operationally is contested, and the skeptical read deserves a hearing. The Information reports Kavukcuoglu was already making day-to-day Gemini calls while Hassabis spent most of his time externally, which makes the 4% single-session drawdown a sentiment move on a formalization of something that already existed. Hassabis also keeps Isomorphic Labs, arguably the most defensible asset DeepMind ever produced, and is reallocating personal time toward AI-for-disease work on the back of AlphaFold's 200 million predicted protein structures. That leaves the genuine fundamental problems narrower than the headline suggests: a delayed flagship and a conceded coding position, both fixable on a two-quarter horizon if the bench holds.


The bench is the asset, and it is priced two ways

Jeff Dean left after 27 years, taking Sanjay Ghemawat, Oriol Vinyals and Quoc Le with him to found Discovery Loop, backed by Radical Ventures and Khosla Ventures at undisclosed terms, with Google itself reported as an early investor. An incumbent writing a check into the startup founded by the chief scientist it just lost is buying an option on a thesis it does not believe it can execute internally at speed. It also establishes, usefully for everyone else raising this year, that automated ML research is fundable at pedigree pricing with no product.

The second price signal is the harder one. Google is reportedly prepared to spend $1.5bn for a 35-person AI coding startup, or roughly $43M per employee, with no ARR anywhere in the calculation. Call that a talent-density floor for sub-40-person teams with frontier pedigree. It sits awkwardly next to evidence that the model layer of coding is commoditizing: Meta went from absent to second on Terminal-Bench 2.1 in one release, behind Claude Code Opus 5 and ahead of Codex, while Google's next flagship slipped. If a fast-follower with a dogfooding loop reaches parity-minus-one in a quarter, "best coding model" is not the moat. Proprietary task data, repository and CI integration depth, and orchestration are.

What would falsify this

The bear case on the talent trade is straightforward, and it is real. Kavukcuoglu ships a strong flagship inside two quarters, equity vesting does the job it was designed to do, and the London exodus simply never happens. Incumbent gravity is powerful and unvested equity remains the most effective retention tool in the industry. The tell is whether the next flagship ships on schedule. The second falsifier is verification: the credible bear case on recursive self-improvement is that it is verification-limited rather than compute-limited, which is precisely the assumption an automated-research thesis needs to survive.

Google bought an option on the thesis it could not execute internally — which tells you the capability it lost was a person, not a platform.

What to do

  1. Commission a map of the senior DeepMind London bench and the two-to-three credible spinout groups within 30 days, briefing portfolio CTOs before those teams price a round.

  2. Re-underwrite holdings with material hyperscaler-capex dependency this quarter against a 20-30% capex growth deceleration, requiring contracted backlog and cohort retention evidence before any follow-on.

  3. Gate any autonomous-science or automated-research entry on one written question this quarter: what is the verification loop that makes recursive research compound, and who owns it?

The bottom line

Today's items share one mechanic: prices investors treat as market-determined — inference, scarce technical talent, a category's last independent asset — were each set by a party earning its return somewhere else on the page. A cost is not a curve and a comp is not a market when both are strategic choices by counterparties indifferent to margin, and they will move again on the same logic. Commission one pass this week asking, per holding, which of its costs and which of its comparables are set by someone who does not need them to be profitable.